MIT nanoparticles for immunotherapy of pancreatic cancer metastases
MIT scientists have created nanoparticles with AND logic for targeted activation of the STING pathway in metastases. Preclinical data: 70% reduction in metastases. Learn about the breakthrough in nanomedicine.
